Dr. Xiangliang Zhang 张相良
Chief Physician
Department of Gastrointestinal Surgery II, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastrointestinal malignancies, including intraperitoneal hyperthermic perfusion chemotherapy.
Dr. Zhang holds a medical doctorate and serves as Chief Physician and master’s supervisor. The doctor was a senior visiting scholar at Harvard Medical School and is recognized as an Outstanding Young Medical Talent in Guangdong Province and a Key Medical Talent in Guangzhou.
Name order: in Chinese the family name comes first (Zhang Xiangliang). Papers usually list the name as Xiangliang Zhang or Zhang X.
Selected publications
25 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Gene, 2024 (senior author): Hyperthermia inhibits the progression of gastric cancer by downregulating PLEK2/PD-L1 and possibly participates in immunomodulation. PubMed 38147897
- J Chemother, 2021 (senior author): Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis. PubMed 33818320
- Biochem Biophys Res Commun, 2021 (senior author): Precision hyperthermia-induced miRNA-409-3p upregulation inhibits migration, invasion, and EMT of gastric cancer cells by targeting KLF17. PubMed 33667708
- Mol Ther Nucleic Acids, 2021 (first author): Blocking the IGF2BP1-promoted glucose metabolism of colon cancer cells via direct de-stabilizing mRNA of the LDHA enhances anticancer effects. PubMed 33614233
- Front Oncol, 2020 (senior author): LncRNA-DANCR Interferes With miR-125b-5p/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis. PubMed 32766131
- Mol Ther Nucleic Acids, 2020 (senior author): The Potential Therapeutic Role of Exosomal MicroRNA-520b Derived from Normal Fibroblasts in Pancreatic Cancer. PubMed 32200272
- Mol Ther Nucleic Acids, 2020 (senior author): hsa_circ_001653 Implicates in the Development of Pancreatic Ductal Adenocarcinoma by Regulating MicroRNA-377-Mediated HOXC6 Axis. PubMed 32193152
- Biosci Rep, 2018 (senior author): Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2. PubMed 29559564
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion